Gene Therapy and Rare Diseases: A Talk with Dr. Donald S. Wood and Mr. Paul Melmeyer
March 5 @ 12:00 pm - 12:30 pm
Join us on March 5 at 12 p.m. Eastern for an Alliance Discussion with Dr. Donald S. Wood, President and CEO of the Muscular Dystrophy Association (MDA), and Paul Melmeyer, Executive Vice President of Public Policy and Advocacy at MDA.
MDA, the 2025 Paul Rogers Distinguished Organization Advocacy Award winner, has been the largest nonprofit supporter of neuromuscular disease research for 75 years, investing over $1 billion in research and gene therapy advancements. In conversation with Research!America CEO Mary Woolley, Dr. Wood and Mr. Melmeyer will discuss the future of gene therapy for ultra-rare conditions and share insights into MDA’s pivotal role in accelerating research and improving care for individuals with neuromuscular diseases.
Bring your questions and join us for this timely discussion on the future of gene therapy and rare disease advocacy.